Biotechnology Havana 2010: Successful healing of Diabetic Ulcers with Heberprot-P

last october 20-22nd, 2010 it was celebrated the 2010 edition to the congress biotechnology havana (bh2010) organized every year by the center for genetic engineering and biotechnology. the bh2010 conference focused on the integral care of diabetic foot ulcer patients with the use of heberprot-p. the congress was attended by 366 delegates from 36 countries. it was organized in two symposia with 6 plenary lectures, 25 lectures and 120 posters. symposia were focused on the molecular biology of growth factors, and the integral care to diabetic foot ulcers, current status, respectively. the bh2010 lectures were given by representatives of 11 countries from the americas, europe and asia, covering the following issues: epidermal growth factor, its molecular biology and other molecules used to promote wound healing, clinical experience on using heberprot-p, therapeutic experience in diabetic foot ulcers and organizational strategies in organizing and extending health services to attend dfu patients. it was evident that heberprot-p emerged as the unique therapy available to successfully cicatrize wagner 3-4 dfus in diabetic patients.